Inspiration Healthcare Group plc

("Inspiration Healthcare", the "Company" or the "Group")

Results presentations for analysts and investors

Inspiration Healthcare Group plc (AIM: IHC), the global medical technology company, announces it will host analyst and investor presentations on Tuesday, 7 October 2025, following the release of its interim results for the 6 months ended 31 July 2025.

Analyst briefing

Raffi Stepanian CEO, and Alan Olby CFO, will host a briefing to equity research analysts on Tuesday 7 October 2025 at 09.30am BST. To register and for more details please contact Walbrook PR on [email protected].

Investor presentation

Management will also provide a live presentation relating to the results via the Investor Meet Company platform on Tuesday, 7 October 2025 at 11.00am BST.  

The presentation is open to all existing and potential shareholders. Questions can be submitted pre-event via the Investor Meet Company dashboard up until 9am the day before the meeting or at any time during the live presentation. Investors can sign up to Investor Meet Company for free and add to meet Inspiration Healthcare.

To register for the presentation, please do so here.  

Investors who already follow Inspiration Healthcare on the Investor Meet Company platform will automatically be invited.

For further information, please contact:

About Inspiration Healthcare

Inspiration Healthcare (AIM: IHC) designs, manufactures and markets pioneering medical technology. Based in the UK, the Company specialises in neonatal intensive care medical devices, which are addressing a critical need to help to save the lives and improve the outcomes of patients, starting with the very first breaths of life.

The Company has a broad portfolio of its own products and complementary distributed products, for use in neonatal intensive care designed to support even the most premature babies throughout their hospital stay. Its own branded products range from highly sophisticated capital equipment such as ventilators for life support through to single-use disposables.

The Company sells its products directly to hospitals and healthcare providers in the UK and Ireland, where it also distributes a range of advanced medical technologies for infusion therapy.  In the rest of the world the Company has an established network of distribution partners around the world giving access to more than 75 countries.

The Company operates in the UK from its world-class Manufacturing and Technology Centre in Croydon, South London and in the USA from its facility in Melbourne, Florida.

Further information on Inspiration Healthcare can be found at www.inspirationhealthcaregroup.com